Amber Curtis
Psychiatric/Mental Health · Camas, WANPI 1386215846
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 197 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 9.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,515 and has fallen 94.9% since, to $77 in 2025. Among psychiatric/mental health clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 197 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$356
- AbbVie$333
- Corium, LLC$300
- Vanda Pharmaceuticals Inc.$293
- Bausch Health US, LLC$286
- Otsuka America Pharmaceutical, Inc.$283
- plus $2K from 13 others
What the payments were for
- Food & beverage$3,658100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 24 | $356 |
| AbbVie | 26 | $333 |
| Corium, LLC | 20 | $300 |
| Vanda Pharmaceuticals Inc. | 18 | $293 |
| Bausch Health US, LLC | 17 | $286 |
| Otsuka America Pharmaceutical, Inc. | 11 | $283 |
| Alkermes, Inc. | 11 | $278 |
| Supernus Pharmaceuticals, Inc. | 16 | $224 |
| Johnson & Johnson | 5 | $223 |
| Teva Pharmaceuticals USA, Inc. | 9 | $220 |
| Lundbeck LLC | 11 | $197 |
| Axsome Therapeutics, Inc. | 6 | $180 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $119 |
| Sunovion Pharmaceuticals Inc. | 7 | $118 |
| Neuronetics, Inc. | 1 | $108 |
| Ironshore Pharmaceuticals Inc. | 4 | $57 |
| Noven Therapeutics, LLC | 2 | $44 |
| Neurocrine Biosciences, Inc. | 2 | $34 |
| Indivior Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$468
- SPRAVATO$150
- Auvelity$111
- REXULTI$110
- NEUROSTAR TMS THERAPY SYSTEM$108
How this compares
$3,666 in reported general payments places this provider in the 90th percentile of 931 psychiatric/mental health providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine | 16 | $73 |
| Clonidine Hcl | 15 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Camas
- Angela CombsRichland$121K
- Ashley McGinnisAuburn$26K
- Courtney YantPuyallup$26K
- Dawn MasonSpokane$25K
- Jennifer WilsonYakima$23K
- Kojo SarfoEllensburg$20K
- Brendan RoeVancouver$18K
- Jenna VoKent$18K
- Kelly BlissSeattle$18K
- Agnes MarambaKent$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.